{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T13:33:38Z","timestamp":1781530418783,"version":"3.54.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.ejim.2023.04.019","type":"journal-article","created":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T16:38:18Z","timestamp":1683045498000},"page":"75-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["The Influence of baseline glycemic status on the effects of intensive blood pressure lowering: Results from the STEP randomized trial"],"prefix":"10.1016","volume":"113","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3429-7765","authenticated-orcid":false,"given":"Ruixue","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anli","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dechao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8928-9570","authenticated-orcid":false,"given":"Jun","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2023.04.019_bib0001","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/CIRCULATIONAHA.115.018912","article-title":"Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries","volume":"134","author":"Mills","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2023.04.019_bib0002","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jama.2013.184182","article-title":"Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries","volume":"310","author":"Chow","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2023.04.019_bib0003","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.2337\/dc18-1307","article-title":"A Comparison of the American college of cardiology\/american heart association blood pressure guideline and the American diabetes association diabetes and hypertension position statement for U.S. adults with diabetes","volume":"41","author":"Muntner","year":"2018","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.ejim.2023.04.019_bib0004","article-title":"Diabetes, hypertension, and cardiovascular disease development","volume":"20","author":"Yen","year":"2022","journal-title":"J Transl Med"},{"key":"10.1016\/j.ejim.2023.04.019_bib0005","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/ajh\/hpt212","article-title":"Short- and long-term survival in treated elderly hypertensive patients with or without diabetes: findings from the second australian national blood pressure study","volume":"27","author":"Chowdhury","year":"2014","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ejim.2023.04.019_bib0006","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S2213-8587(18)30027-5","article-title":"Cardiovascular and renal burdens of prediabetes in the USA: analysis of data from serial cross-sectional surveys, 1988-2014","volume":"6","author":"Ali","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.ejim.2023.04.019_bib0007","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1016\/S0140-6736(12)60283-9","article-title":"Prediabetes: a high-risk state for developing diabetes","volume":"379","author":"Tab\u00e1k","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2023.04.019_bib0008","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.2337\/dc14-0656","article-title":"Regression from prediabetes to normal glucose regulation is associated with reduction in cardiovascular risk: results from the diabetes prevention program outcomes study","volume":"37","author":"Perreault","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejim.2023.04.019_bib0009","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1161\/HYPERTENSIONAHA.118.11063","article-title":"Impacts of prediabetes mellitus alone or plus hypertension on the coronary severity and cardiovascular outcomes","volume":"71","author":"Liu","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.ejim.2023.04.019_bib0010","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1161\/HYPERTENSIONAHA.114.04632","article-title":"Effects of prediabetes mellitus alone or plus hypertension on subsequent occurrence of cardiovascular disease and diabetes mellitus: longitudinal study","volume":"65","author":"Qiu","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.ejim.2023.04.019_bib0011","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.21037\/atm-20-1155","article-title":"Prediabetes and risk for all-cause and cardiovascular mortality based on hypertension status","volume":"8","author":"Huang","year":"2020","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.ejim.2023.04.019_bib0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2018.09.004","article-title":"Prediabetes and cardiovascular disease risk: a nested case-control study","volume":"278","author":"Hu","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejim.2023.04.019_bib0013","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.2337\/dc19-1074","article-title":"Prediabetes and risk for cardiovascular disease by hypertension status in black adults: the jackson heart study","volume":"42","author":"Wu","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejim.2023.04.019_bib0014","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.2337\/dc19-1074","article-title":"Prediabetes and risk for cardiovascular disease by hypertension status in black adults: the jackson heart study","volume":"42","author":"Hubbard","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejim.2023.04.019_bib0015","first-page":"e13","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.ejim.2023.04.019_bib0016","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","article-title":"Effects of intensive blood-pressure control in type 2 diabetes mellitus","volume":"362","author":"Cushman","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2023.04.019_bib0017","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"\u202f\u202fA randomized trial of intensive versus standard blood-pressure control","volume":"373","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2023.04.019_bib0018","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1056\/NEJMoa2111437","article-title":"Trial of intensive blood-pressure control in older patients with hypertension","volume":"385","author":"Zhang","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2023.04.019_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2019.105913","article-title":"Strategy of blood pressure intervention in the elderly hypertensive patients (STEP): rational, design, and baseline characteristics for the main trial","volume":"89","author":"Zhang","year":"2020","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.ejim.2023.04.019_bib0020","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.2337\/dc21-S002","article-title":"\u202f\u202fClassification and diagnosis of diabetes: standards of medical care in diabetes","volume":"44","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejim.2023.04.019_bib0021","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1681\/ASN.2006040368","article-title":"Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease","volume":"17","author":"Ma","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ejim.2023.04.019_bib0022","doi-asserted-by":"crossref","first-page":"21i","DOI":"10.1016\/j.amjcard.2007.03.003","article-title":"Action to control cardiovascular risk in diabetes (ACCORD) trial: design and methods","volume":"99","author":"Buse","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ejim.2023.04.019_bib0023","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.2337\/dc13-2334","article-title":"Outcomes of combined cardiovascular risk factor management strategies in type 2 diabetes: the ACCORD randomized trial","volume":"37","author":"Margolis","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejim.2023.04.019_bib0024","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.009326","article-title":"Effects of intensive systolic blood pressure lowering on cardiovascular events and mortality in patients with type 2 diabetes mellitus on standard glycemic control and in those without diabetes mellitus: reconciling results from ACCORD BP and SPRINT","volume":"7","author":"Beddhu","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ejim.2023.04.019_bib0025","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.2337\/dc17-1722","article-title":"Intensive blood pressure lowering in patients with and patients without type 2 Diabetes: a pooled analysis from two randomized trials","volume":"41","author":"Brouwer","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejim.2023.04.019_bib0026","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.2337\/dc17-1366","article-title":"Intensive versus standard blood pressure control in sprint-eligible participants of ACCORD-BP","volume":"40","author":"Buckley","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejim.2023.04.019_bib0027","doi-asserted-by":"crossref","DOI":"10.2337\/dc17-0885","article-title":"Effect of intensive versus standard blood pressure treatment according to baseline prediabetes status: a post hoc analysis of a randomized trial","author":"Bress","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejim.2023.04.019_bib0028","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s12933-020-01156-8","article-title":"Blood pressure levels and cardiovascular risk according to age in patients with diabetes mellitus: a nationwide population-based cohort study","volume":"19","author":"Kim","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.ejim.2023.04.019_bib0029","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.2337\/dc19-0686","article-title":"Association between early hypertension control and cardiovascular disease incidence in veterans with diabetes","volume":"42","author":"Raghavan","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejim.2023.04.019_bib0030","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S2213-8587(22)00172-3","article-title":"Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis","volume":"10","author":"Nazarzadeh","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.ejim.2023.04.019_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2022.07.005","article-title":"Interaction of blood pressure and glycemic status in developing cardiovascular disease: analysis of a nationwide real-world database","author":"Suzuki","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ejim.2023.04.019_bib0032","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1161\/HYPERTENSIONAHA.121.17981","article-title":"Hypertension in diabetes: an update of basic mechanisms and clinical disease","volume":"78","author":"Jia","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.ejim.2023.04.019_bib0033","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1161\/HYPERTENSIONAHA.117.10546","article-title":"Hypertension and diabetes mellitus: coprediction and time trajectories","volume":"71","author":"Tsimihodimos","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.ejim.2023.04.019_bib0034","first-page":"671","article-title":"Role of hyperinsulinemia and insulin resistance in hypertension: metabolic syndrome revisited","volume":"36","author":"da Silva","year":"2020","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.ejim.2023.04.019_bib0035","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S2213-8587(16)30321-7","article-title":"Comparative prognostic performance of definitions of prediabetes: a prospective cohort analysis of the atherosclerosis risk in communities (ARIC) study","volume":"5","author":"Warren","year":"2017","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620523001310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620523001310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:38:28Z","timestamp":1760607508000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620523001310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":35,"alternative-id":["S0953620523001310"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2023.04.019","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Influence of baseline glycemic status on the effects of intensive blood pressure lowering: Results from the STEP randomized trial","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2023.04.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}